Jove
Visualize
Contact Us

Related Experiment Videos

The evolution of human pathogens: examples and clinical implications.

U Vogel1, H Claus

  • 1Institut für Hygiene und Mikrobiologie, University of Würzburg, Germany. uvogel@hygiene.uni-wuerzburg.de

International Journal of Medical Microbiology : IJMM
|December 2, 2000
PubMed
Summary

Bacterial pathogen evolution is revealed by genome sequencing and pathogenicity research. Understanding plague and meningococcal disease evolution highlights the link between phylogeny, epidemiology, and virulence factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishing semi-automated infection surveillance in obstetrics and gynaecology.

The Journal of hospital infection·2024
Same author

Selective replication and vertical transmission of Ebola virus in experimentally infected Angolan free-tailed bats.

Nature communications·2024
Same author

Inability to work following COVID-19 vaccination-a relevant aspect for future booster vaccinations.

Public health·2023
Same author

Surgery in times of COVID-19-recommendations for hospital and patient management.

Langenbeck's archives of surgery·2020
Same author

Hospital surface contamination with antimicrobial-resistant Gram-negative organisms in Tanzanian regional and tertiary hospitals: the need to improve environmental cleaning.

The Journal of hospital infection·2018
Same author

High carriage rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae among patients admitted for surgery in Tanzanian hospitals with a low rate of endogenous surgical site infections.

The Journal of hospital infection·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Microbiology
  • Evolutionary Biology
  • Genomics

Background:

  • Recent advancements in bacterial genomics and pathogenicity research have significantly reshaped our understanding of pathogen evolution.
  • The study of microbial evolution is crucial for comprehending infectious diseases.

Purpose of the Study:

  • To review current evolutionary concepts of human bacterial pathogens, focusing on plague and meningococcal disease.
  • To illustrate the interplay between molecular phylogeny, epidemiology, and pathogenicity research in understanding pathogen evolution.
  • To discuss the rapid evolution of bacteria in response to changing environmental conditions.

Main Methods:

  • Review of current literature on bacterial evolution, focusing on genomics, molecular phylogeny, and pathogenicity.

Related Experiment Videos

  • Analysis of evolutionary concepts related to specific bacterial pathogens like Yersinia pestis and Neisseria meningitidis.
  • Examination of epidemiological data and pathogenicity factors in the context of microbial evolution.

    • Main Results:

    • Genomic sequencing and pathogenicity research provide new insights into the evolution of human bacterial pathogens.
    • Molecular phylogeny, epidemiology, and pathogenicity research are interconnected in understanding pathogen evolution.
    • Bacteria exhibit remarkable evolutionary velocity, adapting rapidly to environmental changes.

    Conclusions:

    • The evolution of bacterial pathogens is a dynamic process influenced by genomic, epidemiological, and environmental factors.
    • Continued research integrating molecular, epidemiological, and pathogenicity data is essential for understanding and combating infectious diseases.
    • The study of pathogen evolution is critical for public health and the development of novel therapeutic strategies.